ReP USP - Resultado da busca

Artigo de periodico
LDLR and PCSK9 3´UTR variants and their putative effects on microRNA molecular interactions in familial hypercholesterolemia: a computational approach (2023)
Freitas, Renata Caroline Costa de ; Bortolin, Raul Hernandes ; Borges, Jéssica Bassani ; Oliveira, Victor Fernandes de; Hernandez, Carolina Dagli ; Marçal, Elisangela da Silva Rodrigues; Bastos, Gisele Medeiros ; Gonçalves, Rodrigo Marques; Faludi, André Arpad; Silbiger, Vivian Nogueira ; Luchessi, Andre Ducati ; Hirata, Rosario Dominguez Crespo ; Hirata, Mario Hiroyuki
Fonte: Molecular Biology Reports. Unidades: IDPC, FCF
Assuntos: MICRORNAS, HIPERCOLESTEROLEMIA, LIPOPROTEÍNAS LDL
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FREITAS, Renata Caroline Costa de et al. LDLR and PCSK9 3´UTR variants and their putative effects on microRNA molecular interactions in familial hypercholesterolemia: a computational approach. Molecular Biology Reports, v. 50, n. 11, p. 9165-9177, 2023Tradução . . Disponível em: https://dx.doi.org/10.1007/s11033-023-08784-9. Acesso em: 28 jun. 2024.
APA
Freitas, R. C. C. de, Bortolin, R. H., Borges, J. B., Oliveira, V. F. de, Hernandez, C. D., Marçal, E. da S. R., et al. (2023). LDLR and PCSK9 3´UTR variants and their putative effects on microRNA molecular interactions in familial hypercholesterolemia: a computational approach. Molecular Biology Reports, 50( 11), 9165-9177. doi:10.1007/s11033-023-08784-9
NLM
Freitas RCC de, Bortolin RH, Borges JB, Oliveira VF de, Hernandez CD, Marçal E da SR, Bastos GM, Gonçalves RM, Faludi AA, Silbiger VN, Luchessi AD, Hirata RDC, Hirata MH. LDLR and PCSK9 3´UTR variants and their putative effects on microRNA molecular interactions in familial hypercholesterolemia: a computational approach [Internet]. Molecular Biology Reports. 2023 ; 50( 11): 9165-9177.[citado 2024 jun. 28 ] Available from: https://dx.doi.org/10.1007/s11033-023-08784-9
Vancouver
Freitas RCC de, Bortolin RH, Borges JB, Oliveira VF de, Hernandez CD, Marçal E da SR, Bastos GM, Gonçalves RM, Faludi AA, Silbiger VN, Luchessi AD, Hirata RDC, Hirata MH. LDLR and PCSK9 3´UTR variants and their putative effects on microRNA molecular interactions in familial hypercholesterolemia: a computational approach [Internet]. Molecular Biology Reports. 2023 ; 50( 11): 9165-9177.[citado 2024 jun. 28 ] Available from: https://dx.doi.org/10.1007/s11033-023-08784-9
Trabalho de evento-resumo
PCSK9 three-dimensional reconstruction by homology modelling and new LDL receptor interaction regions (2019)
Lopes, Vitor Galvão ; Oliveira, Victor Fernandes de ; Kronenberger, Thales ; Hirata, Mario Hiroyuki ; Hirata, Rosario Dominguez Crespo ; Ferreira, Glaucio Monteiro
Fonte: Proceedings. Nome do evento: International Conference of the Brazilian Association of Bioinformatics and Computational Biology/AB3C. Unidade: FCF
Assuntos: DISLIPIDEMIAS, LIPOPROTEÍNAS LDL
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
LOPES, Vitor Galvão et al. PCSK9 three-dimensional reconstruction by homology modelling and new LDL receptor interaction regions. 2019, Anais.. Campos do Jordão: Associação Brasileira de Bioinformática e Biologia Computacional/AB3C, 2019. . Acesso em: 28 jun. 2024.
APA
Lopes, V. G., Oliveira, V. F. de, Kronenberger, T., Hirata, M. H., Hirata, R. D. C., & Ferreira, G. M. (2019). PCSK9 three-dimensional reconstruction by homology modelling and new LDL receptor interaction regions. In Proceedings. Campos do Jordão: Associação Brasileira de Bioinformática e Biologia Computacional/AB3C.
NLM
Lopes VG, Oliveira VF de, Kronenberger T, Hirata MH, Hirata RDC, Ferreira GM. PCSK9 three-dimensional reconstruction by homology modelling and new LDL receptor interaction regions. Proceedings. 2019 ;[citado 2024 jun. 28 ]
Vancouver
Lopes VG, Oliveira VF de, Kronenberger T, Hirata MH, Hirata RDC, Ferreira GM. PCSK9 three-dimensional reconstruction by homology modelling and new LDL receptor interaction regions. Proceedings. 2019 ;[citado 2024 jun. 28 ]
Trabalho de evento-resumo
Identification of the PCSK9 E32K gain-of-function mutation in a Brazilian patient with familial hypercholesterolemia: a case report (2018)
Los, Bruna; Hernandez, Carolina Dagli; Borges, Jéssica Bassani; Bastos, Gisele Medeiros; Faludi, André Arpad; Hirata, Rosario Dominguez Crespo ; Hirata, Mario Hiroyuki
Fonte: Resumos. Nome do evento: International Symposium on Pathophysiology and Toxicology/ISPAT. Unidade: FCF
Assuntos: LIPOPROTEÍNAS LDL, HIPERCOLESTEROLEMIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
LOS, Bruna et al. Identification of the PCSK9 E32K gain-of-function mutation in a Brazilian patient with familial hypercholesterolemia: a case report. 2018, Anais.. São Paulo: FCF/USP, 2018. Disponível em: http://simpac.wixsite.com/simpac/symposium-publications. Acesso em: 28 jun. 2024.
APA
Los, B., Hernandez, C. D., Borges, J. B., Bastos, G. M., Faludi, A. A., Hirata, R. D. C., & Hirata, M. H. (2018). Identification of the PCSK9 E32K gain-of-function mutation in a Brazilian patient with familial hypercholesterolemia: a case report. In Resumos. São Paulo: FCF/USP. Recuperado de http://simpac.wixsite.com/simpac/symposium-publications
NLM
Los B, Hernandez CD, Borges JB, Bastos GM, Faludi AA, Hirata RDC, Hirata MH. Identification of the PCSK9 E32K gain-of-function mutation in a Brazilian patient with familial hypercholesterolemia: a case report [Internet]. Resumos. 2018 ;[citado 2024 jun. 28 ] Available from: http://simpac.wixsite.com/simpac/symposium-publications
Vancouver
Los B, Hernandez CD, Borges JB, Bastos GM, Faludi AA, Hirata RDC, Hirata MH. Identification of the PCSK9 E32K gain-of-function mutation in a Brazilian patient with familial hypercholesterolemia: a case report [Internet]. Resumos. 2018 ;[citado 2024 jun. 28 ] Available from: http://simpac.wixsite.com/simpac/symposium-publications
Artigo de periodico
Inﬂuence of PCSK9 polymorphisms on plasma lipids and response to atorvastatin treatment in Brazilian subjects (2014)
Anderson, Jacqueline M.; Cerda, Alvaro ; Hirata, Mario Hiroyuki ; Rodrigues, Alice Cristina ; Dórea, Egidio Lima; Bernik, Marcia Martins Silveira; Bertolami, Marcelo Chiara ; Faludi, André Arpad; Hirata, Rosario Dominguez Crespo
Fonte: Journal of Clinical Lipidology. Unidades: FCF, ICB, HU
Assuntos: POLIMORFISMO, COLESTEROL, FARMACOLOGIA, LIPÍDEOS, NUCLEOTÍDEOS, FARMACOGENÉTICA, LIPOPROTEÍNAS LDL, REAÇÃO EM CADEIA POR POLIMERASE, PLASMA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ANDERSON, Jacqueline M. et al. Inﬂuence of PCSK9 polymorphisms on plasma lipids and response to atorvastatin treatment in Brazilian subjects. Journal of Clinical Lipidology, v. 8, n. 3, p. 256-264, 2014Tradução . . Disponível em: https://doi.org/10.1016/j.jacl.2014.02.008. Acesso em: 28 jun. 2024.
APA
Anderson, J. M., Cerda, A., Hirata, M. H., Rodrigues, A. C., Dórea, E. L., Bernik, M. M. S., et al. (2014). Inﬂuence of PCSK9 polymorphisms on plasma lipids and response to atorvastatin treatment in Brazilian subjects. Journal of Clinical Lipidology, 8( 3), 256-264. doi:10.1016/j.jacl.2014.02.008
NLM
Anderson JM, Cerda A, Hirata MH, Rodrigues AC, Dórea EL, Bernik MMS, Bertolami MC, Faludi AA, Hirata RDC. Inﬂuence of PCSK9 polymorphisms on plasma lipids and response to atorvastatin treatment in Brazilian subjects [Internet]. Journal of Clinical Lipidology. 2014 ; 8( 3): 256-264.[citado 2024 jun. 28 ] Available from: https://doi.org/10.1016/j.jacl.2014.02.008
Vancouver
Anderson JM, Cerda A, Hirata MH, Rodrigues AC, Dórea EL, Bernik MMS, Bertolami MC, Faludi AA, Hirata RDC. Inﬂuence of PCSK9 polymorphisms on plasma lipids and response to atorvastatin treatment in Brazilian subjects [Internet]. Journal of Clinical Lipidology. 2014 ; 8( 3): 256-264.[citado 2024 jun. 28 ] Available from: https://doi.org/10.1016/j.jacl.2014.02.008
Artigo de periodico
Molecular mechanisms underlying statin effects on genes involved in the reverse cholesterol transport (2012)
Cerda, Alvaro; Hirata, Mario Hiroyuki ; Hirata, Rosario Dominguez Crespo
Fonte: Drug Metabolism and Drug Interactions. Unidade: FCF
Assuntos: LIPOPROTEÍNAS LDL, COLESTEROL
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CERDA, Alvaro e HIRATA, Mario Hiroyuki e HIRATA, Rosario Dominguez Crespo. Molecular mechanisms underlying statin effects on genes involved in the reverse cholesterol transport. Drug Metabolism and Drug Interactions, v. 27, n. 2, p. 101-111, 2012Tradução . . Disponível em: https://doi.org/10.1515/dmdi-2012-0007. Acesso em: 28 jun. 2024.
APA
Cerda, A., Hirata, M. H., & Hirata, R. D. C. (2012). Molecular mechanisms underlying statin effects on genes involved in the reverse cholesterol transport. Drug Metabolism and Drug Interactions, 27( 2), 101-111. doi:10.1515/dmdi-2012-0007
NLM
Cerda A, Hirata MH, Hirata RDC. Molecular mechanisms underlying statin effects on genes involved in the reverse cholesterol transport [Internet]. Drug Metabolism and Drug Interactions. 2012 ; 27( 2): 101-111.[citado 2024 jun. 28 ] Available from: https://doi.org/10.1515/dmdi-2012-0007
Vancouver
Cerda A, Hirata MH, Hirata RDC. Molecular mechanisms underlying statin effects on genes involved in the reverse cholesterol transport [Internet]. Drug Metabolism and Drug Interactions. 2012 ; 27( 2): 101-111.[citado 2024 jun. 28 ] Available from: https://doi.org/10.1515/dmdi-2012-0007
Artigo de periodico
ABCA1 and ABCG1 expressions are regulated by statins and ezetimibe in Caco-2 cells (2011)
Genvigir, Fabiana Dalla Vecchia; Rodrigues, Alice Cristina ; Cerda, Alvaro; Hirata, Mario Hiroyuki ; Curi, Rui; Hirata, Rosario Dominguez Crespo
Fonte: Drug Metabolism and Drug Interactions. Unidades: FCF, ICB
Assuntos: LIPOPROTEÍNAS LDL, EXPRESSÃO GÊNICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
GENVIGIR, Fabiana Dalla Vecchia et al. ABCA1 and ABCG1 expressions are regulated by statins and ezetimibe in Caco-2 cells. Drug Metabolism and Drug Interactions, v. 26, n. 1, p. 33-36, 2011Tradução . . Disponível em: https://doi.org/10.1515/DMDI.2011.101. Acesso em: 28 jun. 2024.
APA
Genvigir, F. D. V., Rodrigues, A. C., Cerda, A., Hirata, M. H., Curi, R., & Hirata, R. D. C. (2011). ABCA1 and ABCG1 expressions are regulated by statins and ezetimibe in Caco-2 cells. Drug Metabolism and Drug Interactions, 26( 1), 33-36. doi:10.1515/DMDI.2011.101
NLM
Genvigir FDV, Rodrigues AC, Cerda A, Hirata MH, Curi R, Hirata RDC. ABCA1 and ABCG1 expressions are regulated by statins and ezetimibe in Caco-2 cells [Internet]. Drug Metabolism and Drug Interactions. 2011 ; 26( 1): 33-36.[citado 2024 jun. 28 ] Available from: https://doi.org/10.1515/DMDI.2011.101
Vancouver
Genvigir FDV, Rodrigues AC, Cerda A, Hirata MH, Curi R, Hirata RDC. ABCA1 and ABCG1 expressions are regulated by statins and ezetimibe in Caco-2 cells [Internet]. Drug Metabolism and Drug Interactions. 2011 ; 26( 1): 33-36.[citado 2024 jun. 28 ] Available from: https://doi.org/10.1515/DMDI.2011.101
Artigo de periodico
Effects of lipid-lowering drugs on reverse cholesterol transport gene expressions in peripheral blood mononuclear and HepG2 cells (2010)
Genvigir, Fabiana Dalla Vecchia; Rodrigues, Alice Cristina ; Cerda, Alvaro; Arazi, Simone Sorkin; Willrich, Maria Alice Vieira; Oliveira, Raquel; Hirata, Mario Hiroyuki ; Dórea, Egidio Lima; Bernik, Marcia Martins Silveira; Curi, Rui; Hirata, Rosario Dominguez Crespo
Fonte: Pharmacogenomics. Unidades: FCF, HU, ICB
Assuntos: EXPRESSÃO GÊNICA, COLESTEROL, LIPOPROTEÍNAS LDL
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
GENVIGIR, Fabiana Dalla Vecchia et al. Effects of lipid-lowering drugs on reverse cholesterol transport gene expressions in peripheral blood mononuclear and HepG2 cells. Pharmacogenomics, v. 11, n. 9, p. 1235-1246, 2010Tradução . . Disponível em: https://doi.org/10.2217/pgs.10.93. Acesso em: 28 jun. 2024.
APA
Genvigir, F. D. V., Rodrigues, A. C., Cerda, A., Arazi, S. S., Willrich, M. A. V., Oliveira, R., et al. (2010). Effects of lipid-lowering drugs on reverse cholesterol transport gene expressions in peripheral blood mononuclear and HepG2 cells. Pharmacogenomics, 11( 9), 1235-1246. doi:10.2217/pgs.10.93
NLM
Genvigir FDV, Rodrigues AC, Cerda A, Arazi SS, Willrich MAV, Oliveira R, Hirata MH, Dórea EL, Bernik MMS, Curi R, Hirata RDC. Effects of lipid-lowering drugs on reverse cholesterol transport gene expressions in peripheral blood mononuclear and HepG2 cells [Internet]. Pharmacogenomics. 2010 ; 11( 9): 1235-1246.[citado 2024 jun. 28 ] Available from: https://doi.org/10.2217/pgs.10.93
Vancouver
Genvigir FDV, Rodrigues AC, Cerda A, Arazi SS, Willrich MAV, Oliveira R, Hirata MH, Dórea EL, Bernik MMS, Curi R, Hirata RDC. Effects of lipid-lowering drugs on reverse cholesterol transport gene expressions in peripheral blood mononuclear and HepG2 cells [Internet]. Pharmacogenomics. 2010 ; 11( 9): 1235-1246.[citado 2024 jun. 28 ] Available from: https://doi.org/10.2217/pgs.10.93
Artigo de periodico
Impact of cholesterol on ABC and SLC transporters expression and function and its role in disposition variability to lipid-lowering drugs (2009)
Rodrigues, Alice Cristina ; Hirata, Mario Hiroyuki ; Hirata, Rosario Dominguez Crespo
Fonte: Pharmacogenomics. Unidade: FCF
Assuntos: LIPOPROTEÍNAS LDL, HIPERCOLESTEROLEMIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
RODRIGUES, Alice Cristina e HIRATA, Mario Hiroyuki e HIRATA, Rosario Dominguez Crespo. Impact of cholesterol on ABC and SLC transporters expression and function and its role in disposition variability to lipid-lowering drugs. Pharmacogenomics, v. 10, n. 6, p. 1007-1016, 2009Tradução . . Disponível em: https://doi.org/10.2217/pgs.09.18. Acesso em: 28 jun. 2024.
APA
Rodrigues, A. C., Hirata, M. H., & Hirata, R. D. C. (2009). Impact of cholesterol on ABC and SLC transporters expression and function and its role in disposition variability to lipid-lowering drugs. Pharmacogenomics, 10( 6), 1007-1016. doi:10.2217/pgs.09.18
NLM
Rodrigues AC, Hirata MH, Hirata RDC. Impact of cholesterol on ABC and SLC transporters expression and function and its role in disposition variability to lipid-lowering drugs [Internet]. Pharmacogenomics. 2009 ; 10( 6): 1007-1016.[citado 2024 jun. 28 ] Available from: https://doi.org/10.2217/pgs.09.18
Vancouver
Rodrigues AC, Hirata MH, Hirata RDC. Impact of cholesterol on ABC and SLC transporters expression and function and its role in disposition variability to lipid-lowering drugs [Internet]. Pharmacogenomics. 2009 ; 10( 6): 1007-1016.[citado 2024 jun. 28 ] Available from: https://doi.org/10.2217/pgs.09.18
Artigo de periodico
ABCA1 expression and statins: inhibitory effect in peripheral blood mononuclear cells (2009)
Genvigir, Fabiana Dalla Vecchia; Hirata, Mario Hiroyuki ; Hirata, Rosario Dominguez Crespo
Fonte: Pharmacogenomics. Unidade: FCF
Assuntos: EXPRESSÃO GÊNICA, LIPOPROTEÍNAS LDL
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
GENVIGIR, Fabiana Dalla Vecchia e HIRATA, Mario Hiroyuki e HIRATA, Rosario Dominguez Crespo. ABCA1 expression and statins: inhibitory effect in peripheral blood mononuclear cells. Pharmacogenomics, v. 10, n. 6, p. 997-1005, 2009Tradução . . Disponível em: https://doi.org/10.2217/pgs.09.30. Acesso em: 28 jun. 2024.
APA
Genvigir, F. D. V., Hirata, M. H., & Hirata, R. D. C. (2009). ABCA1 expression and statins: inhibitory effect in peripheral blood mononuclear cells. Pharmacogenomics, 10( 6), 997-1005. doi:10.2217/pgs.09.30
NLM
Genvigir FDV, Hirata MH, Hirata RDC. ABCA1 expression and statins: inhibitory effect in peripheral blood mononuclear cells [Internet]. Pharmacogenomics. 2009 ; 10( 6): 997-1005.[citado 2024 jun. 28 ] Available from: https://doi.org/10.2217/pgs.09.30
Vancouver
Genvigir FDV, Hirata MH, Hirata RDC. ABCA1 expression and statins: inhibitory effect in peripheral blood mononuclear cells [Internet]. Pharmacogenomics. 2009 ; 10( 6): 997-1005.[citado 2024 jun. 28 ] Available from: https://doi.org/10.2217/pgs.09.30
Trabalho de evento-resumo periodico
Association between polymorphism of the hepatic uptake transporter SLCO1B1 and reduced atrovastatin response (2009)
Rodrigues, Alice Cristina ; Perin, P. M.; Purim, S.; Genvigir, Fabiana Dalla Vecchia; Willrich, Maria Alice Vieira; Arazi, Simone Sorkin; Hirata, Mario Hiroyuki ; Dórea, Egidio Lima; Bernik, Marcia Martins Silveira; Hirata, Rosario Dominguez Crespo
Fonte: Clinical Chemistry. Nome do evento: Annual Meeting of the American Association for Clinical Chemistry. Unidades: FCF, HU
Assunto: LIPOPROTEÍNAS LDL
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
RODRIGUES, Alice Cristina et al. Association between polymorphism of the hepatic uptake transporter SLCO1B1 and reduced atrovastatin response. Clinical Chemistry. Washington: American Association for Clinical Chemistry. . Acesso em: 28 jun. 2024. , 2009
APA
Rodrigues, A. C., Perin, P. M., Purim, S., Genvigir, F. D. V., Willrich, M. A. V., Arazi, S. S., et al. (2009). Association between polymorphism of the hepatic uptake transporter SLCO1B1 and reduced atrovastatin response. Clinical Chemistry. Washington: American Association for Clinical Chemistry.
NLM
Rodrigues AC, Perin PM, Purim S, Genvigir FDV, Willrich MAV, Arazi SS, Hirata MH, Dórea EL, Bernik MMS, Hirata RDC. Association between polymorphism of the hepatic uptake transporter SLCO1B1 and reduced atrovastatin response. Clinical Chemistry. 2009 ; 55( 6 suppl.): A87 res. B-120.[citado 2024 jun. 28 ]
Vancouver
Rodrigues AC, Perin PM, Purim S, Genvigir FDV, Willrich MAV, Arazi SS, Hirata MH, Dórea EL, Bernik MMS, Hirata RDC. Association between polymorphism of the hepatic uptake transporter SLCO1B1 and reduced atrovastatin response. Clinical Chemistry. 2009 ; 55( 6 suppl.): A87 res. B-120.[citado 2024 jun. 28 ]
Trabalho de evento-resumo
Efeitos de fármacos hipocolesterolemiantes na expressão gênica da apolipoproteína E (2006)
Oliveira, Verônica Simões de; Sorkin, Simone Cohen; Willrich, Maria Alice Vieira; Vecchia, Fabiana Dalla; Hirata, Mario Hiroyuki ; Hirata, Rosario Dominguez Crespo
Fonte: Resumos. Nome do evento: Simpósio Internacional de Iniciação Científica da Universidade de São Paulo - SIICUSP. Unidade: FCF
Assuntos: FÁRMACOS (EFEITOS), EXPRESSÃO GÊNICA, HIPERCOLESTEROLEMIA, LIPOPROTEÍNAS LDL
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
OLIVEIRA, Verônica Simões de et al. Efeitos de fármacos hipocolesterolemiantes na expressão gênica da apolipoproteína E. 2006, Anais.. São Paulo: USP, 2006. . Acesso em: 28 jun. 2024.
APA
Oliveira, V. S. de, Sorkin, S. C., Willrich, M. A. V., Vecchia, F. D., Hirata, M. H., & Hirata, R. D. C. (2006). Efeitos de fármacos hipocolesterolemiantes na expressão gênica da apolipoproteína E. In Resumos. São Paulo: USP.
NLM
Oliveira VS de, Sorkin SC, Willrich MAV, Vecchia FD, Hirata MH, Hirata RDC. Efeitos de fármacos hipocolesterolemiantes na expressão gênica da apolipoproteína E. Resumos. 2006 ;[citado 2024 jun. 28 ]
Vancouver
Oliveira VS de, Sorkin SC, Willrich MAV, Vecchia FD, Hirata MH, Hirata RDC. Efeitos de fármacos hipocolesterolemiantes na expressão gênica da apolipoproteína E. Resumos. 2006 ;[citado 2024 jun. 28 ]
Artigo de periodico
Growth hormone promotes glomerular lipid accumulation in bGH mice (2005)
Machado, Marcos O.; Hirata, Rosario Dominguez Crespo ; Sellitti, Donald F.; Iotti, Roberto; Iotti, Alejandro; Cusumano, Ana M.; Riordan, Gavin P.; Coschigano, Karen T.; Kopchick, John J.; Zuhl, Irina; Nguyen, Nga; Hirata, Mario Hiroyuki ; Doi, Sonia Quatelli
Fonte: Kidney International. Unidade: FCF
Assuntos: LIPOPROTEÍNAS LDL, CITOCINAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MACHADO, Marcos O. et al. Growth hormone promotes glomerular lipid accumulation in bGH mice. Kidney International, v. 68, n. 5, p. 2219-2028, 2005Tradução . . Disponível em: https://doi.org/10.1111/j.1523-1755.2005.00656.x. Acesso em: 28 jun. 2024.
APA
Machado, M. O., Hirata, R. D. C., Sellitti, D. F., Iotti, R., Iotti, A., Cusumano, A. M., et al. (2005). Growth hormone promotes glomerular lipid accumulation in bGH mice. Kidney International, 68( 5), 2219-2028. doi:10.1111/j.1523-1755.2005.00656.x
NLM
Machado MO, Hirata RDC, Sellitti DF, Iotti R, Iotti A, Cusumano AM, Riordan GP, Coschigano KT, Kopchick JJ, Zuhl I, Nguyen N, Hirata MH, Doi SQ. Growth hormone promotes glomerular lipid accumulation in bGH mice [Internet]. Kidney International. 2005 ; 68( 5): 2219-2028.[citado 2024 jun. 28 ] Available from: https://doi.org/10.1111/j.1523-1755.2005.00656.x
Vancouver
Machado MO, Hirata RDC, Sellitti DF, Iotti R, Iotti A, Cusumano AM, Riordan GP, Coschigano KT, Kopchick JJ, Zuhl I, Nguyen N, Hirata MH, Doi SQ. Growth hormone promotes glomerular lipid accumulation in bGH mice [Internet]. Kidney International. 2005 ; 68( 5): 2219-2028.[citado 2024 jun. 28 ] Available from: https://doi.org/10.1111/j.1523-1755.2005.00656.x

Unidades USP

ReP

Filtros

Departamento

Autores

Autores USP

Ano de publicação

Assuntos

Título da fonte

Indexado em

Afiliação dos autores externos não normalizada